Pneumococcal meningitis vaccine breakthroughs and failures after routine 7-valent and 13-valent pneumococcal conjugate vaccination in children in France

Pediatric Infectious Disease Journal

Volumn 34, Issue 10, 2015, Pages e260-e263

  Godot, Cecile ^a,b   Levy, Corinne ^a,b,c   Varon, Emmanuelle ^d   Picard, Capucine ^e,f   Madhi, Fouad ^a,b   Cohen, Robert ^a,b  

^a Groupe de Pathologie Infectieuse Pediatrique de la Societe Francaise de Pediatrie   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c ACTIV Association Clinique et Therapeutique Infantile du Val de Marne   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f IMAGINE INSTITUTE   (France)

Author keywords

Children; Pneumococcal conjugate vaccine; Pneumococcal meningitis; Vaccine breakthrough; Vaccine failure

Indexed keywords

PNEUMOCOCCUS VACCINE; VACCINE;

ARTICLE; CHILD; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; SEROTYPE; VACCINATION; VACCINE FAILURE; ADOLESCENT; IMMUNOLOGY; INFANT; MENINGITIS, PNEUMOCOCCAL; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TREATMENT FAILURE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES; TREATMENT FAILURE; VACCINES, CONJUGATE;

EID: 84942068420     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000818     Document Type: Article

References (14)

1. Kaplan SL, Barson WJ, Lin PL, et al. Early trends for invasive pneumococ-cal infections in children after the introduction of the 13-valent pneumococ-cal conjugate vaccine. Pediatr Infect Dis J. 2013;32:203-207.
2. Institut de veille sanitaire. Vaccination Schedule for 2008. Recommendations from the Haut Conseil de la Santé Publique; 2008; 16-17: 129-47. Available at: http://www.invs.sante.fr/beh/2008/16-17. Accessed April 21, 2008.
3. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360:244-256.
4. Institut de veille sanitaire. French Vaccinal Calendar Recommendations; 2010. Available at: http://www.invs.sante.fr/beh/2010/14-15. Accessed April 22, 2010.
5. Levy C, Varon E, Picard C, et al. Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France. Pediatr Infect Dis J. 2014;33:1216-1221.
6. Heininger U, Bachtiar NS, Bahri P, et al. The concept of vaccination failure. Vaccine. 2012;30:1265-1268.
7. Park SY, Van Beneden CA, Pilishvili T, et al; Active Bacterial Core surveillance team. Invasive pneumococcal infections among vaccinated children in the United States. J Pediatr. 2010;156:478-483.e2.
8. Harboe ZB, Valentiner-Branth P, Ingels H, et al; Danish Pneumococcal Surveillance Collaborating Group. Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark. PLoS One. 2013;8:e51460.
9. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children-Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2010; 59: 258-261.
10. Ladhani SN, Slack M P, Andrews NJ, et al. Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales. Emerg Infect Dis. 2013;19:61-68.
11. Bryant KA, Block SL, Baker SA, et al; PCV13 Infant Study Group. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics. 2010;125:866-875.
12. Cohen R, Levy C, Bonnet E, et al. Dynamic of pneumococcal nasopharyn-geal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine. 2010;28:6114-6121.
13. Andrews NJ, Waight PA, Burbidge P, et al. Serotype-specifc effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014;14:839-846.
14. Gaschignard J, Levy C, Chrabieh M, et al. Invasive pneumococcal disease in children can reveal a primary immunodefciency. Clin Infect Dis. 2014;59:244-251.